The ability to establish a latent infection with periodic reactivation events ensures herpesviruses, like 11 human cytomegalovirus (HCMV), lifelong infection and serial passage. The host-pathogen 12 relationship throughout HCMV latency is complex, though both cellular and viral factors influence 13 the equilibrium between latent and lytic infection. We and others have shown one of the viral-14 encoded G protein-coupled receptors, US28, is required for HCMV latency. US28 potentiates signals 15 both constitutively and in response to ligand binding, and we previously showed deletion of the 16 ligand binding domain or mutation of the G protein-coupling domain results in the failure to maintain 17 latency similar to deletion of the entire US28 open reading frame (ORF). Interestingly, a recent 18 publication detailed an altered phenotype from that previously reported, showing US28 is required 19
Introduction 29
Human cytomegalovirus (HCMV) is a ubiquitous pathogen that latently infects the majority of the 30 population (Khanna and Diamond, 2006) . Latent infection in healthy individuals rarely poses a 31 significant health risk, however immune dysregulation can lead to reactivation and CMV-associated 32 disease, which can be fatal ( Ljungman et al., 2017) . This underscores the need to better understand these phases of viral infection 34 to prevent disease and improve patient outcomes. 35 36 Our current understanding of the biological mechanisms controlling latency and reactivation 37 remain incomplete, though work from many labs have detailed the importance of both host and viral 38 factors in these processes (Collins-McMillen et al., 2018; Elder and Sinclair, 2019) . We and others 39 have shown the viral G protein-coupled receptor (GPCR) US28 is required for viral latency (Humby 40 and O'Connor, 2015; Wu and Miller, 2016 ; Krishna et al., 2017; Krishna et al., 2019) . US28 is 41 expressed during both latent and lytic infection , and we were the first to detail 42 its requirement for successful HCMV latent infection (Humby and O'Connor, 2015) . Building upon 43 our original work, we more recently showed US28 regulates the expression and activity of cellular 44 fos (c-fos) , a component of the activator protein-1 (AP-1) transcription factor 45 complex (Halazonetis et al., 1988 ). US28's attenuation of c-fos leads to a decrease in AP-1 binding 46 to the major immediate early promoter (MIEP) , a key regulator in the latent-to-47 lytic switch (Collins-McMillen et al., 2018) . Additionally, our data revealed a requirement for G 48 protein-coupling, and to a lesser extent, ligand binding to US28, suggesting US28-mediated signaling 49
is important for this phenotype . This is consistent with findings from the 50 Sinclair Lab, who showed US28 is required for latency in monocytes. Their work also detailed 51 specific signaling pathways US28 impacts to ensure MIEP silencing in these latently-infected cells 52 (Krishna et al., 2017; . Finally, Wu and Miller showed infection of THP-1 53 monocytes with a US28-deletion mutant resulted in robust IE1/2 protein expression, compared to 54 cultures infected with virus expressing US28 (Wu and Miller, 2016 As this is a legitimate concern, we generated an additional set of viral recombinants using an 69 additional BAC-derived clinical isolate, FIX (BFXwt-GFP; wt). We constructed a triple flag-tagged 70 US28 recombinant (BFX-GFPinUS28-3xF; inUS28-3xF), from which we then inserted a stop codon 71
immediately following the first methionine (BFX-GFPstopUS28; stopUS28). Using these 72
independently-generated viruses, we now show, consistent with our previous work ( μ g/ml gentamicin at a density of 5 x 10 5 to 1 x 10 6 cells/ml. Murine stromal 93 cells S1/S1 and M2-10B4 (MG3) were kind gifts from Terry Fox Laboratories, BC Cancer Agency 94 (Vancouver, BC, Canada). S1/S1 cells were maintained in Iscove's modified Dulbecco's medium 95 (IMDM), supplemented with 10% FBS, 1 mM sodium pyruvate, and 100 U/ml each of penicillin and 96 streptomycin. MG3 cells were maintained in RPMI 1640, supplemented with 10% FBS and 100 U/ml 97 each of penicillin and streptomycin. S1/S1 and MG3 cells were plated in a 1:1 ratio (~1.5 x 10 5 cells 98 of each cell type) onto collagen-coated (1 mg/ml) 6-well plates in human CD34 + long-term culture 99 media (hLTCM), containing MyeloCult H5100 (Stem Cell Technologies, cat#5150) supplemented 100 with 1 μ M hydrocortisone, and 100 U/ml each of penicillin and streptomycin. The next day, the cells 101
were irradiated using a fixed source 137 Cesium, Shepherd Mark I Irradiator at 20 Gy, after which the 102 cells were washed three times with 1X PBS, then resuspended in fresh hLTCM and returned to 103 culture. Irradiated murine stromal cells were utilized the following day as feeder cells for the primary 104 CD34 + hematopoietic progenitor cells (HPCs Table 1 ). 118
This product was then used to generate BFX-GFP-inUS28-3xF by recombination (e.g. ref. (O'Connor  119 and Shenk, 2011). BFXwt-GFP-inUS28-3xF was then used to generate two independent US28 stop 120 mutants using galK recombineering, as described previously (O'Connor and Miller, 2014) . Briefly, 121
the galK gene was amplified by PCR using primers listed in Supplementary Table 1 . Recombination-122 competent SW105 Escherichia coli containing BFX-GFP-inUS28-3xF were transformed with the 123 resulting PCR product. GalK-positive clones were selected and electroporated with the double 124 stranded reversion oligoucleotide ( Supplementary Table 1 ) and mutants were counter-selected 125 against galK. Two independently generated mutants, BFX-GFP-stopUS28-S1 and BFX-GFP-126
stopUS28-S2, were validated by Sanger sequencing. The multiple epitope tag viral GPCR mutant 127 was generated using TB40/EmCherry-US28-3xF as a backbone. Each of the remaining three viral 128
GPCRs were serially epitope tagged with the primers in Supplementary Table 1 , and recombinant 129 clones were sequenced following each reversion. The resulting virus, multi-tag vGPCR 130 (vGPCRmulti), contains the following epitope tags: US28-3xF, US27-3xHA, UL33-c-myc, and 131 UL78-V5. vGPCRmulti was then used to generate vGPCRmulti-US28Δ using galK recombineering 132
techniques. The primers used to generate this mutant are previously described (Miller et al., 2012) . 133
The sequence for vGPCRmulti-US28Δ was verified by Sanger sequencing. All viral stocks were 134 propagated and titered by 50% tissue culture infectious dose (TCID 50 ) as described (e.g. ref.
135
(O'Connor and Shenk, 2012). 136
Viral Growth Analyses 137
Multi-step growth assays were performed using fibroblasts (MRC-5, NuFF-1) by infecting cells at a 138 multiplicity of infection (moi) of 0.01 TCID 50 /cell. Infectious supernatants were collected over a time 139
course of infection and stored at -80°C until processing. Infectious virus was then titrated on naïve 140 fibroblasts (MRC-5, NuFF-1) and analyzed by TCID 50 assay. 141
Viral RNA & Protein Assays 142
For viral transcript analyses, primary NuFF-1 fibroblasts were infected at an moi = 0.5 TCID 50 /cell. Sigma,  171 cat#A3854, RRID:AB_262011; 1:20,000), and goat-anti-mouse (cat#115-035-003, 172 RRID:AB_10015289) or goat-anti-rat (cat#112-035-003, RRID:AB_2338128) horseradish 173 peroxidase (HRP) secondary (Jackson ImmunoResearch Labs; 1:10,000). 174
Latency Infection & Extreme Limiting Dilution Assay 175
Kasumi-3 cells (moi = 1.0) were infected as described previously (e.g. ref. . 176 Briefly, cells were cultured in serum-low media (XVIVO-15; Lonza, cat#04-418Q) for 48h prior to 177 infection. Kasumi-3 cells were infected at a density of 5.0 x 10 5 cells/ml by centrifugal enhancement. 178
At 7 days post-infection (dpi), cultures were treated with 20nM 12-O-tetredecanoylphorbol-13-179 acetate (TPA) or vehicle (DMSO) for an additional 2d. Infectious particle production was assessed by 180
Extreme Limiting Dilution Assay (ELDA) on naïve NuFF-1 fibroblasts, as described previously 181 (Umashankar and Goodrum, 2014) . 182
Primary CD34 + HPC culture and infection conditions are described elsewhere (Umashankar 183 and Goodrum, 2014) . Briefly, CD34 + HPCs (moi = 2.0) were infected by centrifugal enhancement, 184
followed by overnight incubation. Cells were washed and cultured over irradiated MG3:S1/S1 185 murine stromal cells (plated at 1:1 ratio, see above). At 7 dpi, a portion of each infected cell 186 population was cultured in reactivation media (RPMI 1640, containing 20% FBS, 10 mM HEPES, 1 187 mM sodium pyruvate, 2 mM L-glutamine, 0.1 mM nonessential amino acids, 100 U/ml each 188 penicillin and streptomycin, with 15 ng/ml each (all from R&D Systems): IL-6, G-CSF, GM-CSF, 189 IL-3) or maintained in hLTCM. Infectious particle production was assessed by ELDA on naïve 190
NuFF-1 fibroblasts, as detailed elsewhere (Umashankar and Goodrum, 2014) . 191 192 3
Results 193
stopUS28 virus replicates to wild type titers in fibroblasts 194
To ensure US28's function is due to the absence of only this protein as opposed to potential off-site 195 consequences resulting from deletion of the US28 ORF, we generated a new panel of recombinants 196
using the BAC-derived, clinical isolate, BFXwt-GFP (wt) (Murphy et al., 2008) . The first variant, 197 BFX-GFPinUS28-3xF (inUS28-3xF) expresses a pUS28 fusion protein with three, tandem FLAG 198 epitope repeats in the C-terminus of the protein (Fig 1A) . Similar to our work in another BAC-199 derived clinical isolate, TB40/E, in which we made an identical tagged pUS28 recombinant virus 200 (Miller et al., 2012) , we observed robust pUS28 expression following lytic infection of fibroblasts by 201 both immunofluorescence assay (IFA; Fig 1B) and immunoblot ( Fig 1C) . infected fibroblasts, consistent with the assembly complex . Next, we generated 204 two independently derived BFX-GFPstopUS28 constructs using the inUS28-3xF backbone (Fig 1A) , 205 allowing us to confirm protein ablation by both western blot analysis ( Fig 1B) and IFA ( Fig 1C) . , we found pUS28 is not required for efficient viral replication in 208 lytically infected fibroblasts, as the two, independently generated stop mutants grew to wild type 209 titers ( Supplementary Fig 1) . Together, these data confirm pUS28 expression is ablated in stopUS28-210 infected fibroblasts, and pUS28 is dispensable for lytic replication in these cells. 211 authors posited that complete ORF deletion possibly impacted efficient expression of surrounding 221 genes, thus potentially contributing to the discrepancies in phenotypes between this and previous 222 studies (Crawford et al., 2019) . To determine if our newly generated US28 stop mutant displayed a 223 similar phenotype during latent infection, we infected Kasumi-3 and cord blood-derived CD34 + cells 224
stopUS28 fails to maintain latency in hematopoietic cells
with wt or stopUS28 for 7d under latent conditions. We then divided each infected culture, treating 225 half with reactivation stimuli for an additional 2d, where we treated Kasumi-3-infected cultures with 226 TPA and cultured primary CD34 + HPCs in reactivation media. We then quantified the production of 227 infectious particles by extreme limiting dilution assay (ELDA) on naïve fibroblasts. stopUS28-228
infected cells failed to maintain a latent infection, as Kasumi-3 or CD34 + cells infected with this 229 mutant produced infectious virus regardless of reactivation stimuli treatment (Fig 2) . These data 230 suggest ablating pUS28 by either introduction of a stop codon or deletion of the ORF results in a 231 variant incapable of maintaining latency in hematopoietic cells. 232
Deletion of the US28 ORF does not impact US27 or US29 transcription or US27 protein 233 expression 234
While we observed no difference in the outcome of a US28 stop mutant versus a US28 ORF deletion 235 mutant, we were concerned this mutation may affect neighboring viral transcripts, such as US27, 236
which is encoded along with US28 as a polycistronic transcript (Balazs et al., 2017) . Thus, to ensure 237 US27 and US29 mRNA expression are unaffected by altered pUS28 expression, we assessed each of 238 these transcripts following lytic infection of fibroblasts with BFXwt-GFP or BFXstopUS28, as well 239 as TB40/EmCherry or TB40/EmCherry-US28Δ. We chose to evaluate these transcripts during the 240 lytic life cycle because neither of these genes is expressed during latency (Humby and O'Connor, 241 2015; Cheng et al., 2017; Shnayder et al., 2018) . To this end, we lytically infected fibroblasts (moi = 242 0.5), harvested total RNA at 96 hpi, and performed RTqPCR to quantify US27 and US29 transcripts, 243
as well as US28, UL123, and UL99 as controls. We found ablating pUS28 expression did not impact 244 the transcription of US27 or US29 in either US28 recombinant virus (Fig 3) . Since US27 and US28 245 originate from a polycistronic RNA, we also assessed US27 protein (pUS27) expression in the 246 context of US28 ORF deletion. To this end, we generated a virus construct in the TB40/EmCherry 247 background that contains a different epitope tag on the C-terminus of each viral-encoded GPCR, 248
termed TB40/EmCherry-vGPCRmulti (vGPCRmulti). Each vGPCR is tagged as follows: US27-249 3xHA, US28-3xF, UL33-myc, and UL78-V5 ( Supplementary Fig 2A) . Using this construct, we then 250 generated a US28 deletion, including the triple FLAG epitope tag, termed vGPCRmulti-US28Δ 251
( Supplementary Fig 2A) , which replicated with wild type kinetics ( Supplementary Fig 2B) . We then 252 used these newly-generated viral recombinants to lytically infect fibroblasts (moi = 0.5) to determine 253 their localization and expression by IFA and immunoblot, respectively. vGPCRmulti-infected 254
fibroblasts express each of the four vGPCRs ( Supplementary Fig 3) , while vGPCRmulti-US28Δ fails 255 to express pUS28, as expected (Fig 4) . Importantly, complete ORF deletion of US28 does not impact 256 pUS27 expression ( Fig 4A) or localization ( Fig 4B) , consistent with our transcriptional data (Fig 3) . 257
Together, these data suggest ablation of pUS28 expression does not impact US27 and US29 258 expression. 259 7 260 4
Discussion 261
Our findings using newly generated recombinant HCMV constructs reveal pUS28 expression is 262 required for HCMV latency. Our data confirm previous work, wherein we and other groups 263 demonstrated US28 ORF deletion viruses favor lytic rather than latent infection in hematopoietic 264 cells. We now show the insertion of a stop codon after the first methionine in the US28 ORF in the 265
BFXwt-GFP background ablates protein expression, which, similar to the US28 ORF deletion virus 266
we previously generated in the TB40/E background, results in a lytic-like infection of both Kasumi-3 267
and cord blood-derived CD34 + cells. Our data also suggest US27 and US29 gene expression are not 268
impacted by the lack of pUS28 expression, as the US28 stop and deletion viruses express these 269 neighboring transcripts to wild type levels during lytic infection. (Crawford et al., 2019) . It is possible, therefore, that while these cells fully support HCMV 317 latency and reactivation, the underlying biological mechanisms the virus uses are distinct from those 318 it employs in cells of hematopoietic origin. It would prove interesting to determine the outcome of 319
infecting the fetal liver-derived CD34 + cells with our viral constructs in the future, which may reveal 320 novel differences, while highlighting similarities, with regards to the function of this key protein in 321 different setting. 322
In sum, our work presented herein reveals pUS28 expression is critical to HCMV latency. 323
Further, our data reveal the deletion of the US28 ORF from our constructs does not impact the 324 expression of the polycistronic transcript, US27, or that of the downstream US29 gene. While we and 325 others have begun to interrogate the signaling pathways pUS28 potentiates to maintain viral latency, 326
further work aimed at understanding the cellular and viral factors pUS28 manipulates during this 327 phase of infection will provide insight into the HCMV-host relationship. 328 5
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